S. Segato

ORCID: 0000-0003-4971-615X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Eosinophilic Esophagitis
  • Microscopic Colitis
  • Celiac Disease Research and Management
  • Inflammatory Bowel Disease
  • Gastrointestinal disorders and treatments
  • Biliary and Gastrointestinal Fistulas
  • Helicobacter pylori-related gastroenterology studies
  • Liver Disease Diagnosis and Treatment
  • Hepatitis B Virus Studies
  • Esophageal and GI Pathology
  • Hepatitis C virus research
  • Colorectal Cancer Screening and Detection
  • Gastric Cancer Management and Outcomes
  • Gastroesophageal reflux and treatments
  • Gastrointestinal Bleeding Diagnosis and Treatment
  • Neuroendocrine Tumor Research Advances
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Liver Disease and Transplantation
  • Diverticular Disease and Complications
  • Gallbladder and Bile Duct Disorders
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Ultrasound in Clinical Applications
  • Abdominal Trauma and Injuries
  • Radiology practices and education
  • Immunotherapy and Immune Responses

Ospedale di Circolo e Fondazione Macchi
2015-2023

Aziende Socio Sanitarie Territoriale dei Sette Laghi
2022-2023

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2019-2021

University of Milan
2017-2019

Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
2019

Vita-Salute San Raffaele University
2019

Istituti di Ricovero e Cura a Carattere Scientifico
2019

University of Insubria
2017

The use of ustekinumab and vedolizumab as second-line therapies in patients with Crohn's disease (CD) which tumour necrosis factor alpha inhibitors (TNFi) failed is still debated. aim this study was to compare, a large multicenter observational retrospective cohort, the effectiveness therapies, assessed by clinical objective outcomes including endoscopy gastrointestinal imaging.Clinical response, remission, steroid-free remission at weeks 26 52 were evaluated propensity score-weighted...

10.14309/ajg.0000000000001773 article EN cc-by The American Journal of Gastroenterology 2022-04-13

Aims Pancreatic metastases are rare neoplastic lesions and data on metastatic pancreatic tumors diagnosed by fine needle aspiration (FNA) or biopsy (FNB) limited. We report a two centres experience of FNA/FNB secondary tumors. Aim this study is identify which neoplasms may lead to higher risk developing define the prevalence condition in pancreas endoscopic ultrasound examinations with cytological histological lesion sampling (FNA-FNB).

10.1055/s-0044-1783452 article EN Endoscopy 2024-04-01

10.1007/s12682-010-0048-4 article EN Journal of Medicine and the Person 2010-07-15

10.1016/s1590-8658(09)60222-x article IT Digestive and Liver Disease 2009-03-01
Coming Soon ...